Miriam H Terkelsen, Alex Iranzo, Mónica Serradell, Andreas M Baun, Morten G Stokholm, Erik Hvid Danielsen, Karen Østergaard, Marit Otto, Kristina B Svendsen, Mette Møller, Erik L Johnsen, Alicia Garrido, Dolores Vilas, Joan Santamaria, Arne Møller, Carles Gaig, David J Brooks, Per Borghammer, Eduardo Tolosa, Nicola Pavese
BACKGROUND AND PURPOSE: Most patients with isolated rapid eye movement sleep behaviour disorder (iRBD) progress to a parkinsonian alpha-synucleinopathy. However, time to phenoconversion shows great variation. The aim of this study was to investigate whether cholinergic and dopaminergic dysfunction in iRBD patients was associated with impending phenoconversion. METHODS: Twenty-one polysomnography-confirmed iRBD patients underwent baseline 11 C-donepezil and 6-Fluoro-(18 F)-l-3,4-dihydroxyphenylalanine (18 F-DOPA) positron emission tomography (PET)...
October 3, 2024: European Journal of Neurology